Literature DB >> 19237519

Role of LecA and LecB lectins in Pseudomonas aeruginosa-induced lung injury and effect of carbohydrate ligands.

Chanez Chemani1, Anne Imberty, Sophie de Bentzmann, Maud Pierre, Michaela Wimmerová, Benoît P Guery, Karine Faure.   

Abstract

Pseudomonas aeruginosa is a frequently encountered pathogen that is involved in acute and chronic lung infections. Lectin-mediated bacterium-cell recognition and adhesion are critical steps in initiating P. aeruginosa pathogenesis. This study was designed to evaluate the contributions of LecA and LecB to the pathogenesis of P. aeruginosa-mediated acute lung injury. Using an in vitro model with A549 cells and an experimental in vivo murine model of acute lung injury, we compared the parental strain to lecA and lecB mutants. The effects of both LecA- and Lec B-specific lectin-inhibiting carbohydrates (alpha-methyl-galactoside and alpha-methyl-fucoside, respectively) were evaluated. In vitro, the parental strain was associated with increased cytotoxicity and adhesion on A549 cells compared to the lecA and lecB mutants. In vivo, the P. aeruginosa-induced increase in alveolar barrier permeability was reduced with both mutants. The bacterial burden and dissemination were decreased for both mutants compared with the parental strain. Coadministration of specific lectin inhibitors markedly reduced lung injury and mortality. Our results demonstrate that there is a relationship between lectins and the pathogenicity of P. aeruginosa. Inhibition of the lectins by specific carbohydrates may provide new therapeutic perspectives.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19237519      PMCID: PMC2681743          DOI: 10.1128/IAI.01204-08

Source DB:  PubMed          Journal:  Infect Immun        ISSN: 0019-9567            Impact factor:   3.441


  35 in total

1.  Synthesis and binding properties of divalent and trivalent clusters of the Lewis a disaccharide moiety to Pseudomonas aeruginosa lectin PA-IIL.

Authors:  Karine Marotte; Cathy Préville; Charles Sabin; Myriame Moumé-Pymbock; Anne Imberty; René Roy
Journal:  Org Biomol Chem       Date:  2007-08-07       Impact factor: 3.876

2.  Structural basis for the interaction between human milk oligosaccharides and the bacterial lectin PA-IIL of Pseudomonas aeruginosa.

Authors:  Stéphanie Perret; Charles Sabin; Claire Dumon; Martina Pokorná; Catherine Gautier; Oxana Galanina; Shahov Ilia; Nicolai Bovin; Magali Nicaise; Michel Desmadril; Nechama Gilboa-Garber; Michaela Wimmerová; Edward P Mitchell; Anne Imberty
Journal:  Biochem J       Date:  2005-07-15       Impact factor: 3.857

Review 3.  Treatment and control of severe infections caused by multiresistant Pseudomonas aeruginosa.

Authors:  G M Rossolini; E Mantengoli
Journal:  Clin Microbiol Infect       Date:  2005-07       Impact factor: 8.067

Review 4.  Carbohydrates as future anti-adhesion drugs for infectious diseases.

Authors:  Nathan Sharon
Journal:  Biochim Biophys Acta       Date:  2006-01-18

5.  The Pseudomonas aeruginosa lectins PA-IL and PA-IIL are controlled by quorum sensing and by RpoS.

Authors:  K Winzer; C Falconer; N C Garber; S P Diggle; M Camara; P Williams
Journal:  J Bacteriol       Date:  2000-11       Impact factor: 3.490

6.  Interactions of the fucose-specific Pseudomonas aeruginosa lectin, PA-IIL, with mammalian glycoconjugates bearing polyvalent Lewis(a) and ABH blood group glycotopes.

Authors:  A M Wu; J H Wu; T Singh; J-H Liu; M-S Tsai; N Gilboa-Garber
Journal:  Biochimie       Date:  2006-05-24       Impact factor: 4.079

7.  Alveolar response to Pseudomonas aeruginosa: role of the type III secretion system.

Authors:  F Ader; R Le Berre; K Faure; P Gosset; O Epaulard; B Toussaint; B Polack; E Nowak; N B Viget; E Kipnis; B P Guery
Journal:  Infect Immun       Date:  2005-07       Impact factor: 3.441

8.  The key role of Pseudomonas aeruginosa PA-I lectin on experimental gut-derived sepsis.

Authors:  R S Laughlin; M W Musch; C J Hollbrook; F M Rocha; E B Chang; J C Alverdy
Journal:  Ann Surg       Date:  2000-07       Impact factor: 12.969

9.  The mink as an animal model for Pseudomonas aeruginosa adhesion: binding of the bacterial lectins (PA-IL and PA-IIL) to neoglycoproteins and to sections of pancreas and lung tissues from healthy mink.

Authors:  Svend Kirkeby; Michaela Wimmerová; Dennis Moe; Axel K Hansen
Journal:  Microbes Infect       Date:  2007-02-20       Impact factor: 2.700

10.  X-ray structures and thermodynamics of the interaction of PA-IIL from Pseudomonas aeruginosa with disaccharide derivatives.

Authors:  Karine Marotte; Charles Sabin; Cathy Préville; Myriam Moumé-Pymbock; Michaela Wimmerová; Edward P Mitchell; Anne Imberty; René Roy
Journal:  ChemMedChem       Date:  2007-09       Impact factor: 3.466

View more
  74 in total

1.  Lcl of Legionella pneumophila is an immunogenic GAG binding adhesin that promotes interactions with lung epithelial cells and plays a crucial role in biofilm formation.

Authors:  Carla Duncan; Akriti Prashar; Jannice So; Patrick Tang; Donald E Low; Mauricio Terebiznik; Cyril Guyard
Journal:  Infect Immun       Date:  2011-03-21       Impact factor: 3.441

2.  Pseudomonas aeruginosa potentiates the lethal effect of intestinal ischemia-reperfusion injury: the role of in vivo virulence activation.

Authors:  David Fink; Kathleen Romanowski; Vesta Valuckaite; Trissa Babrowski; Moses Kim; Jeffrey B Matthews; Donald Liu; Olga Zaborina; John C Alverdy
Journal:  J Trauma       Date:  2011-12

3.  The sigma factor AlgU plays a key role in formation of robust biofilms by nonmucoid Pseudomonas aeruginosa.

Authors:  Alexis Bazire; Kouki Shioya; Emmanuelle Soum-Soutéra; Emeline Bouffartigues; Cynthia Ryder; Linda Guentas-Dombrowsky; Gaëlle Hémery; Isabelle Linossier; Sylvie Chevalier; Daniel J Wozniak; Olivier Lesouhaitier; Alain Dufour
Journal:  J Bacteriol       Date:  2010-03-26       Impact factor: 3.490

4.  Virulence factors as predictive tools for drug resistance in Pseudomonas aeruginosa.

Authors:  Sónia Gonçalves Pereira; Ana Cristina Rosa; Olga Cardoso
Journal:  Virulence       Date:  2015-05-07       Impact factor: 5.882

Review 5.  Pseudomonas biofilm matrix composition and niche biology.

Authors:  Ethan E Mann; Daniel J Wozniak
Journal:  FEMS Microbiol Rev       Date:  2012-01-23       Impact factor: 16.408

6.  Electronic detection of lectins using carbohydrate-functionalized nanostructures: graphene versus carbon nanotubes.

Authors:  Yanan Chen; Harindra Vedala; Gregg P Kotchey; Aymeric Audfray; Samy Cecioni; Anne Imberty; Sébastien Vidal; Alexander Star
Journal:  ACS Nano       Date:  2011-12-08       Impact factor: 15.881

Review 7.  A review on anti-adhesion therapies of bacterial diseases.

Authors:  Arezoo Asadi; Shabnam Razavi; Malihe Talebi; Mehrdad Gholami
Journal:  Infection       Date:  2018-10-01       Impact factor: 3.553

8.  Pseudomonas aeruginosa-mediated damage requires distinct receptors at the apical and basolateral surfaces of the polarized epithelium.

Authors:  Iwona Bucior; Keith Mostov; Joanne N Engel
Journal:  Infect Immun       Date:  2009-12-14       Impact factor: 3.441

Review 9.  Multivalent glycoconjugates as anti-pathogenic agents.

Authors:  Anna Bernardi; Jesus Jiménez-Barbero; Alessandro Casnati; Cristina De Castro; Tamis Darbre; Franck Fieschi; Jukka Finne; Horst Funken; Karl-Erich Jaeger; Martina Lahmann; Thisbe K Lindhorst; Marco Marradi; Paul Messner; Antonio Molinaro; Paul V Murphy; Cristina Nativi; Stefan Oscarson; Soledad Penadés; Francesco Peri; Roland J Pieters; Olivier Renaudet; Jean-Louis Reymond; Barbara Richichi; Javier Rojo; Francesco Sansone; Christina Schäffer; W Bruce Turnbull; Trinidad Velasco-Torrijos; Sébastien Vidal; Stéphane Vincent; Tom Wennekes; Han Zuilhof; Anne Imberty
Journal:  Chem Soc Rev       Date:  2012-12-19       Impact factor: 54.564

10.  Leaf Extracts of Selected Gardening Trees Can Attenuate Quorum Sensing and Pathogenicity of Pseudomonas aeruginosa PAO1.

Authors:  Kaimin Niu; Min Kuk; Haein Jung; Kokgan Chan; Sooki Kim
Journal:  Indian J Microbiol       Date:  2017-07-12       Impact factor: 2.461

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.